Lonidamine can enhance the cytotoxic effect of cisplatin in human tumour cells and rodent cells.

Abstract

Lonidamine combined with cisplatin treatment was tested in human glioma (U87MG) human squamous cell carcinoma (UMSCCl) and Chinese hamster (HA1) cells. The order of sensitivity to cisplatin was HA1 greater than U87MG greater than UMSCCl. Lonidamine caused little sensitization in U87MG cells, moderate sensitization in HA1 cells and large sensitization in… (More)

Topics

  • Presentations referencing similar topics